Advertisement
Research Article

Significance Analysis of Prognostic Signatures

  • Andrew H. Beck mail,

    abeck2@bidmc.harvard.edu (AHB); bhaibeka@ircm.qc.ca (BHK)

    Affiliation: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Nicholas W. Knoblauch,

    Affiliation: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Marco M. Hefti,

    Affiliation: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Jennifer Kaplan,

    Affiliation: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Stuart J. Schnitt,

    Affiliation: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Aedin C. Culhane,

    Affiliations: Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Markus S. Schroeder,

    Affiliations: Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Thomas Risch,

    Affiliations: Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • John Quackenbush,

    Affiliations: Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America, Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

    X
  • Benjamin Haibe-Kains mail

    abeck2@bidmc.harvard.edu (AHB); bhaibeka@ircm.qc.ca (BHK)

    Affiliation: Bioinformatics and Computational Genomics Laboratory, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada

    X
  • Published: January 24, 2013
  • DOI: 10.1371/journal.pcbi.1002875

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.